Kazia Therapeutics Ltd - Company Profile

Powered by

All the sales intelligence you need on Kazia Therapeutics Ltd in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Kazia Therapeutics Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Kazia Therapeutics Ltd.

Back to companies

Kazia Therapeutics Ltd: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Kazia Therapeutics Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Kazia Therapeutics Ltd's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Dr. John Friend

Chief Executive Officer; Managing Director Executive Board Since: 2023

Dr. John Friend has been the Chief Executive Officer and Managing Director of the company since 2023. Prior to this, he served as Chief Medical Officer at Cellectar Biosciences Inc. Previously, Dr. Friend also served as the Senior Vice President of Medical and Scientific Affairs for the US business unit of Helsinn Therapeutics.

Read Hide full bio of Dr. John Friend

Sudha Rao

Chief Scientific Officer Senior Management Since: 2026

Dr. Sudha Rao has been the Chief Scientific Officer of the company since April 2026. Previously, she served as Chief Scientific Officer of EpiAxis Therapeutics.

Read Hide full bio of Sudha Rao

Bryce Carmine

Chairman Non Executive Board Since: 2024

Mr. Bryce Carmine has been the Chairman of the company since January 2024. He also serves as the Chairman and Chief Executive Officer of HaemaLogiX Pty Ltd. Prior to this, he served as the Executive Vice President at Eli Lilly & Co and President at Lilly Bio-Medicines. Previously, he served as the President at Eli Lilly Japan, Managing Director of Australia/NZ and General Manager at JV for Eli Lilly in Seoul, Korea.

Read Hide full bio of Bryce Carmine

Jeffrey Bonacorda

Vice President - Finance; Controller Senior Management Since: 2024

Elissa Hansen

Secretary Senior Management Since: 2024
Gain a 360-degree view of Kazia Therapeutics Ltd and make more informed decisions for your business Gain a 360-degree view of Kazia Therapeutics Ltd and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer